Liposomal Meningococcal B Vaccination: Role of Dendritic Cell Targeting in the Development of a Protective Immune Response
Carmen Arigita(Utrecht University), Wim Jiskoot(Diagnostics for the Real World (United Kingdom)), Daan J.A. Crommelin(Utrecht University), Gerben A. Koning(Università Cattolica del Sacro Cuore), Linda A. Everse(Utrecht University), Lisette Bevaart(University Medical Center Utrecht), Martine J. van Vugt(University Medical Center Utrecht), Gideon Kersten(Leiden University), Jan G. J. van de Winkel(Genmab (United States)), Wim E. Hennink(Utrecht University)
Cited by 59
Related Papers
mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability
|International Journal of Pharmaceutics|2021|1.5k
Extrinsic Fluorescent Dyes as Tools for Protein Characterization
|Pharmaceutical Research|2008|1.2k
Overcoming Limitations in Nanoparticle Drug Delivery: Triggered, Intravascular Release to Improve Drug Penetration into Tumors
|Cancer Research|2012|458
Biology of Human Immunoglobulin G Fc Receptors
|Journal of Leukocyte Biology|1991|399
Current and next generation influenza vaccines: Formulation and production strategies
|European Journal of Pharmaceutics and Biopharmaceutics|2015|327